The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course.
The number of confirmed new coronavirus cases per day in the U.S. hit an all-time high of 40,000 Friday — eclipsing the mark set during one of the deadliest stretches in late April.
As nations grapple with new outbreaks and spiking death tolls from the coronavirus, a commonly available drug appeared Tuesday to offer hope that the most seriously ill could have a better chance of survival.
Death rates are 12 times higher for coronavirus patients with chronic illnesses than for others who become infected, a new U.S. government report says.
A new poll suggests Americans have remarkably little interest in big changes to health care as a result of the pandemic.
An alliance of world leaders is holding a virtual summit Monday hoping to drum up billions of dollars to fund research into a vaccine for the new coronavirus as well as develop better treatments and more efficient testing.
The guidance is focused on when those workers can return to work after having been exposed to the new coronavirus.
After 76 days in lockdown, the Chinese city at the heart of the global pandemic reopened Wednesday, and tens of thousands immediately hopped on trains and planes to leave.
The case study examines the success the hospital has achieved from integrating two innovative technologies to improve stroke treatment processes and speed communications for the condition.
We know drones as children’s toys, from videos and maybe from the military. But drones are much more than that, and Falck is now testing how drones can be a help in health and treatment.